BackNextCell Pharma AB Overview

NextCell Pharma AB Total Liabilities

Track NextCell Pharma AB's total liabilities ($17M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$16.83M

Peer trimmed avg / median

Loading

NextCell Pharma AB Total Liabilities History

Loading

NextCell Pharma AB vs. peers: Total Liabilities Comparison

Loading

NextCell Pharma AB Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NextCell Pharma AB (NXTCL.ST) FAQ

As of the most recent data (June 2026), NXTCL.ST shows a total liabilities of $17M. Scroll down for historical charts and peer comparison views.

Tracking NXTCL.ST's total liabilities over time shows whether NextCell Pharma AB is scaling, shrinking, or reshaping that part of the business. The current reading is $17M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has NextCell Pharma AB's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $17M) with ownership activity and broader fundamentals.

NextCell Pharma AB's total liabilities is $17M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.